Nanobiotix Secures Up to $71 Million in Royalty Financing from HealthCare Royalty
Nanobiotix SA has secured up to $71 million in non-dilutive financing through a royalty monetization agreement with Healthcare Royalty (HCRx). The deal includes an upfront payment of $50 million, with an additional $21 million expected after one year, contingent on certain conditions. The funding will support the advancement of Nanobiotix’s nanotherapeutics platforms and extend its cash runway into early 2028, particularly for head and neck and lung cancer developments. HCRx will receive a capped portion of milestones and royalties on sales of JNJ-1900 (NBTXR3). TD Cowen acted as the financial advisor.
Nanobiotix SA has entered into a strategic royalty monetization agreement with Healthcare Royalty (HCRx) for up to $71 million in non-dilutive financing. Under the terms of the deal, Nanobiotix will receive an upfront payment of $50 million and expects an additional $21 million one year after closing, contingent on certain conditions. The funding will be used to advance Nanobiotix’s nanotherapeutics platforms and extend its cash runway into early 2028, supporting development milestones in head and neck and lung cancer. HCRx will receive a capped portion of milestones and royalties on sales of JNJ-1900 (NBTXR3) under Nanobiotix’s global licensing agreement, with payments structured through the transfer of receivables to a French law trust. TD Cowen acted as sole financial advisor to Nanobiotix. Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Nanobiotix SA published the original content used to generate this news brief via GlobeNewswire (Ref. ID: GNW9565960-en) on October 31, 2025, and is solely responsible for the information contained therein. © Copyright 2025 - Public Technologies (PUBT)
